Liraglutide Weight Loss
CAS 204656-20-2
Appearance: White powder
Purity(HPLC): ≥98.0%
Single Impurity(HPLC): ≤1.0%
Acetate Content(HPLC): 5.0%~12.0%
Water Content (Karl Fischer): ≤10.0%
Assay:99%
Delivery time:12h after your payment
Packing:Discreet package for delivery guarantee
Delivery terms:HKEMS,DHL,TNT,EMS,Fedex,UPS
Description
Manufacture : Peptides Melanotan //Semaglutide// Liraglutide/Dulaglutide Powder

What is Liraglutide?
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic GLP-1 that stimulates insu.lin secretion.
Marketed under the brand name Victoza,Liraglutide is an injectable developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing Liraglutide in the U.S. and E.U. under the brand name as a treatment for adults, who are obese or overweight with at least one weight-relatedcomorbid condition.
What Is The Difference Between Liraglutide And Semaglutide?
1. Molecular Structure and Origin:
- Liraglutide:
Liraglutide is a long-acting GLP-1 receptor agonist derived from human GLP-1 by amino acid substitution.
- Semaglutide:
Semaglutide is also a long-acting GLP-1 receptor agonist but has a slightly different structure that allows it to bind more strongly to the GLP-1 receptor, resulting in a longer half-life.
2. Efficacy and Outcomes:
- Liraglutide:
Clinical studies have shown that liraglutide effectively lowers blood glucose levels and promotes weight loss. It has been a cornerstone in the management of type 2 diabetes for its ability to improve glycemic control and cardiovascular outcomes.
- Semaglutide:
Semaglutide has demonstrated superior efficacy in lowering HbA1c and promoting weight loss compared to liraglutide. Studies have shown it to be more effective in reducing body weight and managing blood sugar levels, potentially due to its longer half-life and stronger receptor affinity.
3. Side Effects:
- Liraglutide:
Common side effects include nausea, vomiting, diarrhea, and constipation. Some patients may experience injection site reactions or develop antibodies against the medication.
- Semaglutide:
Similar side effects to liraglutide, with gastrointestinal issues being the most common. However, due to its weekly dosing, some patients may experience fewer fluctuations in side effects.
In summary, while both liraglutide and semaglutide are effective GLP-1 receptor agonists used for diabetes and weight management, semaglutide's longer duration of action, higher efficacy in lowering HbA1c and promoting weight loss, and less frequent dosing make it a preferred option for many patients.

| Product Name | Liraglutide |
| CAS | 204656-20-2 |
| Appearance | White |
| Molecular Formula | C172H265N43O51 |
| Molecular Weight | 144.076 |
| Assay | >99% |
| Application | For research purpose only |
| Storage | Store in a well-closed,light-resistant container |
| Remarks | NA |
| Custom synthesis | Available |


How To Cooperate With Us?
--Contact us via Email.
--Leave us a message about the products you want.
--Description of order quantity.
--Please tell us your shipping address.
--The sales manager gives you a quote and sends you a contract.
--Delivery the same day after payment.

Hot Tags: liraglutide weight loss, China, suppliers, manufacturers, factory, wholesale, buy, bulk, price, for sale, in stock
Send Inquiry
You Might Also Like







